SMS Pharmaceuticals Limited — Results, 22-05-2026: Integrated Filing- Financial

SMS Pharmaceuticals reported strong consolidated results for the year ended March 31, 2026. Revenue from operations rose 13.30% YoY to Rs 886.87 Cr, driven by its Active Pharmaceutical Ingredients (API) segment. Net profit surged 47.51% YoY to Rs 101.99 Cr, with EPS at Rs 11.15. A significant boost to profitability came from a substantial increase in the share of profit from its associate company. While operating expenses saw moderate increases, improved inventory trends also contributed. The Board proposed a final dividend of Rs 0.40 per share. These results reflect strong financial momentum and strategic contributions.